Getein Biotech, Inc
Status: Publicly traded
Direct answer
Getein Biotech, Inc is publicly traded on SHH under the ticker 603387.SS.
Getein Biotech, Inc. is an enterprise primarily focused on the research, development, manufacturing, and global distribution of in vitro diagnostic (IVD) solutions. Founded in 2002 and based in Nanjing, China, the company offers a comprehensive array of diagnostic products. This includes a variety of diagnostic reagents, advanced analytical instruments, and crucial calibrators. Getein also supplies foundational raw...
Can you invest in Getein Biotech, Inc?
Yes. Getein Biotech, Inc is publicly traded on SHH under the ticker 603387.SS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Getein Biotech, Inc
Detailed equity research is provided by MarketSnap.